Penumbra (MEX:PEN) Cyclically Adjusted Revenue per Share: MXN336.98 (As of Mar. 2026)


MEX:PEN Penumbra Inc MEX:PEN
89 GF Score
Price MXN4,775.70
GF Value MXN4,993.79
! 1 Warning Sign
View Full Analysis

What is Penumbra Cyclically Adjusted Revenue per Share?

Penumbra MEX:PEN 89 Cyclically Adjusted Revenue per Share is MXN336.98 as of Mar. 2026. GuruFocus rates MEX:PEN with a GF Score™ of 89/100 and a GF Value™ of MXN4,993.79. The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Penumbra's adjusted revenue per share for the three months ended in Mar. 2026 was MXN170.896. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is MXN336.98 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Penumbra's average Cyclically Adjusted Revenue Growth Rate was 15.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-07-11), Penumbra's current stock price is MXN4775.70. Penumbra's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was MXN336.98. Penumbra's Cyclically Adjusted PS Ratio of today is 14.17.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Penumbra was 16.30. The lowest was 9.44. And the median was 13.01.


Penumbra  (MEX:PEN) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Penumbra's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=4775.70/336.98
=14.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Penumbra was 16.30. The lowest was 9.44. And the median was 13.01.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Penumbra Cyclically Adjusted Revenue per Share Related Terms


Penumbra Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Penumbra's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Penumbra Cyclically Adjusted Revenue per Share Chart

Penumbra Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 398.56 338.54

Penumbra Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 369.93 401.74 402.69 338.54 336.98

MEX:PEN vs GMED, PODD, BRKR: Cyclically Adjusted Revenue per Share Comparison

For the Medical Devices subindustry, Penumbra's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Penumbra Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Penumbra's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Penumbra's Cyclically Adjusted PS Ratio falls into.


MEX:PEN
89GF Score
Penumbra Inc MEX:PEN
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Penumbra Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Penumbra's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=170.896/330.2130*330.2130
=170.896

Current CPI (Mar. 2026) = 330.2130.

Penumbra Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 36.149 241.018 49.527
201609 38.486 241.428 52.639
201612 44.580 241.432 60.973
201703 43.608 243.801 59.064
201706 43.852 244.955 59.115
201709 42.699 246.819 57.126
201712 43.892 246.524 58.792
201803 51.948 249.554 68.738
201806 59.650 251.989 78.167
201809 61.064 252.439 79.877
201812 56.235 251.233 73.914
201903 68.800 254.202 89.372
201906 71.184 256.143 91.769
201909 75.930 256.759 97.652
201912 75.402 256.974 96.892
202003 88.554 258.115 113.289
202006 68.533 257.797 87.784
202009 92.174 260.280 116.940
202012 91.302 260.474 115.747
202103 92.148 264.877 114.878
202106 97.596 271.696 118.616
202109 103.937 274.310 125.119
202112 108.008 278.802 127.925
202203 104.879 287.504 120.459
202206 110.979 296.311 123.677
202209 113.353 296.808 126.111
202212 113.400 296.797 126.168
202303 111.355 301.836 121.824
202306 114.362 305.109 123.772
202309 120.336 307.789 129.103
202312 122.910 306.746 132.313
202403 117.415 312.332 124.137
202406 141.394 314.175 148.612
202409 151.298 315.301 158.454
202412 160.684 315.605 168.121
202503 169.326 319.799 174.840
202506 162.862 322.561 166.726
202509 165.549 324.800 168.308
202512 176.053 324.054 179.399
202603 170.896 330.213 170.896

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of MXN336.98 mean?
Penumbra (MEX:PEN) has a Cyclically Adjusted Revenue per Share of MXN336.98 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Penumbra and its competitors.
Is Penumbra's Cyclically Adjusted Revenue per Share too high?
Penumbra's current Cyclically Adjusted Revenue per Share is MXN336.98. Overall, Penumbra has a GF Score™ of 89/100, reflecting its overall financial health beyond just this single metric.
How does Penumbra's Cyclically Adjusted Revenue per Share compare to GMED and PODD?
Penumbra's Cyclically Adjusted Revenue per Share of MXN336.98 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Penumbra and its competitors. Penumbra's current Cyclically Adjusted Revenue per Share is MXN336.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Penumbra stock overvalued right now?
Penumbra (MEX:PEN) has a current Cyclically Adjusted Revenue per Share of MXN336.98. The stock's GF Value™ is MXN4,993.79, compared to a current price of MXN4,775.70 — trading 4.4% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is MXN336.98. Penumbra's overall GF Score™ is 89/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Penumbra (MEX:PEN), the current Cyclically Adjusted Revenue per Share is MXN336.98 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Penumbra (MEX:PEN) Overvalued in 2026?

Based on GuruFocus' analysis, Penumbra stock appears to be undervalued. The current stock price of MXN4,775.70 is trading 4.4% below its estimated GF Value™ of MXN4,993.79.

Key valuation signals for MEX:PEN:

  • Cyclically Adjusted Revenue per Share: MXN336.98
  • GF Value™: MXN4,993.79 vs. price of MXN4,775.70 (4.4% below fair value)
  • GF Score™: 89/100 with 1 warning sign

No single metric tells the full story. See the MEX:PEN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Penumbra Business Description

Other Exchanges PEN:USA0P8:Germany
Address 1310 Harbor Bay Parkway, One Penumbra Place, Alameda, CA, USA, 94502
Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.
89GF Score

Get the complete analysis for MEX:PEN

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN4,775.70
Price
MXN4,993.79
GF Value